Fluorine-19 or phosphorus-31 NMR spectroscopy: A suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs

被引:84
作者
Martino, R [1 ]
Gilard, V [1 ]
Desmoulin, F [1 ]
Malet-Martino, M [1 ]
机构
[1] Univ Toulouse 3, CNRS, UMR 5068, Grp RMN Biomed,Lab SPCMIB, F-31062 Toulouse, France
关键词
F-19; NMR; P-31; in vitro quantification; biological fluids; excised tissues; cell pellet; fluoropyrimidine drugs; oxazaphosphorine drugs;
D O I
10.1016/j.jpba.2005.01.047
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Fluorine-19 or phosphorus-31 NMR (F-19 NMR or P-31 NMR) spectroscopy provides a highly specific tool for identification of fluorine- or phosphorus-containing drugs and their metabolites in biological media as well as a suitable analytical technique for their absolute quantification. This article focuses on the application of in vitro F-19 or P-31 NMR to the quantitative metabolic studies of some fluoropyrimidine or oxazaphosphorine drugs in clinical use. The first part presents an overview of the advantages (non-destructive and non-selective direct quantitative study of the biological matrices) and limitations (expensive cost of the spectrometers, limited mass or concentration sensitivity) of NMR spectroscopy. The second part deals with the criteria to be considered for successful quantification by NMR (uniform excitation over the entire spectral width of the spectrum, resonance signals properly characterised by taking into account T-1 values and avoiding NOE enhancements, optimisation of the data processing, choice of a suitable standard reference). The third and fourth parts report some examples of quantification of 5-fluorouracil, its prodrug capecitabine, 5-fluorocytosine and their metabolites in bulk solutions (biofluids, tissue extracts, perfusates and culture media) and heterogeneous media (excised tissues and packed intact cells) as well as cyclophosphamide and ifosfamide in biofluids. These two parts emphasise the high potential of in vitro F-19 or P-31 NMR for absolute quantification, in a single run, of all the fluorine- or phosphorus-containing species in the matrices analysed. The limit of quantification in bulk solutions is 1-3 mu M for F-19 NMR and approximately 10 mu M for P-31 NMR. In heterogeneous media analysed with F-19 NMR, it is 2-5 nmol in excised tissues and cell pellets. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:871 / 891
页数:21
相关论文
共 98 条
[21]  
FASOLA G, 1991, HAEMATOLOGICA, V76, P120
[22]  
Fleming RA, 1997, PHARMACOTHERAPY, V17, pS146
[23]  
Friebolin H, 1998, BASIC ONE 2 DIMENSIO
[24]   In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method [J].
Gade, TPF ;
Spees, WM ;
Le, HC ;
Zakian, KL ;
Ponomarev, V ;
Doubrovin, M ;
Gelovani, JG ;
Koutcher, JA .
MAGNETIC RESONANCE IN MEDICINE, 2004, 52 (01) :169-173
[25]   DETERMINATION OF THE URINARY-EXCRETION OF IFOSFAMIDE AND ITS PHOSPHORATED METABOLITES BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
GILARD, V ;
MALETMARTINO, MC ;
DEFORNI, M ;
NIEMEYER, U ;
ADER, JC ;
MARTINO, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (05) :387-394
[26]   Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions [J].
Gilard, V ;
Martino, R ;
Malet-Martino, M ;
Niemeyer, U ;
Pohl, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (14) :2542-2560
[27]   INVIVO F-19-NMR OF 5-FLUOROURACIL INCORPORATION INTO RNA AND METABOLITES IN ESCHERICHIA-COLI-CELLS [J].
GOCHIN, M ;
JAMES, TL ;
SHAFER, RH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 804 (01) :118-124
[28]  
GOREN MP, 1986, LANCET, V2, P1219
[29]  
GREM JL, 1996, CANC CHEMOTHERAPY BI, P149
[30]   METABOLISM AND ACTIONS OF 2-DEOXY-2-FLUORO-D-GALACTOSE INVIVO [J].
GRUN, BR ;
BERGER, U ;
OBERDORFER, F ;
HULL, WE ;
OSTERTAG, H ;
FRIEDRICH, E ;
LEHMANN, J ;
KEPPLER, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (01) :11-19